These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12680564)

  • 1. AIDS vaccine for Africa.
    Trop Doct; 2003 Apr; 33(2):128. PubMed ID: 12680564
    [No Abstract]   [Full Text] [Related]  

  • 2. AIDS vaccine research becomes 'big science'.
    Butler D
    Nature; 2006 Aug; 442(7103):610-1. PubMed ID: 16900166
    [No Abstract]   [Full Text] [Related]  

  • 3. Market incentives, human lives, and AIDS vaccines.
    Craddock S
    Soc Sci Med; 2007 Mar; 64(5):1042-56. PubMed ID: 17113203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS vaccine duo.
    Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988492
    [No Abstract]   [Full Text] [Related]  

  • 5. Broken promises.
    Nature; 2008 Apr; 452(7187):503. PubMed ID: 18385689
    [No Abstract]   [Full Text] [Related]  

  • 6. Betting big on an AIDS vaccine.
    Nat Med; 2005 Jun; 11(6):579. PubMed ID: 15937450
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV/AIDS: money matters.
    Roberts L; Jasny B
    Science; 2008 Jul; 321(5888):511. PubMed ID: 18653875
    [No Abstract]   [Full Text] [Related]  

  • 8. Partnership for HIV vaccine research in Africa.
    Sanders E
    Ethiop Med J; 2003 Jun; 41 Suppl 1():5-7. PubMed ID: 15227875
    [No Abstract]   [Full Text] [Related]  

  • 9. Large sum awarded for development of protein vaccine candidate.
    IAVI Rep; 2011; 15(3):17. PubMed ID: 21809802
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV: The societal costs of failing to develop a vaccine.
    Norris J
    BMJ; 2007 Jul; 335(7610):60. PubMed ID: 17626923
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS vaccines. G8 leaders endorse global effort.
    Vogel G
    Science; 2004 Jun; 304(5678):1728. PubMed ID: 15205499
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to 'One for the money'.
    Snow B
    Nat Med; 2005 Aug; 11(8):817. PubMed ID: 16079868
    [No Abstract]   [Full Text] [Related]  

  • 13. One for the money.
    Mandavilli A
    Nat Med; 2005 Jun; 11(6):587-8. PubMed ID: 15937461
    [No Abstract]   [Full Text] [Related]  

  • 14. US Senate approves $48 billion global AIDS funding.
    Nature; 2008 Jul; 454(7203):381. PubMed ID: 18650879
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS vaccines. The first shot in a highly targeted strategy.
    Cohen J
    Science; 2004 Nov; 306(5700):1276-7. PubMed ID: 15550634
    [No Abstract]   [Full Text] [Related]  

  • 16. Search for AIDS vaccine at risk because of lack of interest and funding.
    AIDS Read; 2005 Oct; 15(10):497. PubMed ID: 16265764
    [No Abstract]   [Full Text] [Related]  

  • 17. Industrial strength research. Collaborative efforts in AIDS vaccine research are adopting some characteristics common in the biopharmaceutical industry.
    Zandonella C
    IAVI Rep; 2006; 10(1):1, 6-8. PubMed ID: 16625718
    [No Abstract]   [Full Text] [Related]  

  • 18. Canadians, Gates unite to conduct AIDS vaccine research.
    AIDS Policy Law; 2007 Mar; 22(5):2. PubMed ID: 17387798
    [No Abstract]   [Full Text] [Related]  

  • 19. Gates of opportunity.
    Sorenson E
    Nature; 2007 May; 447(7143):502-3. PubMed ID: 17554811
    [No Abstract]   [Full Text] [Related]  

  • 20. Call for tighter vaccine funding restrictions.
    AIDS Patient Care STDS; 2005 Nov; 19(11):784. PubMed ID: 16317814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.